BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17307749)

  • 1. Significance of time-course changes of serum bone markers after parathyroidectomy in patients with uraemic hyperparathyroidism.
    Yajima A; Inaba M; Ogawa Y; Tominaga Y; Tanizawa T; Inou T; Otsubo O
    Nephrol Dial Transplant; 2007 Jun; 22(6):1645-57. PubMed ID: 17307749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early changes of bone histology and circulating markers of bone turnover after parathyroidectomy in hemodialysis patients with severe hyperparathyroidism.
    Yajima A; Tanaka K; Tominaga Y; Ogawa Y; Tanizawa T; Inou T; Otsubo O; Otsubo K
    Clin Nephrol; 2001 Jul; 56(1):27-34. PubMed ID: 11499656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary hyperparathyroidism: bone structure, balance, and remodeling before and 3 years after surgical treatment.
    Steiniche T; Christiansen P; Vesterby A; Ullerup R; Hessov I; Mosekilde LE; Melsen F
    Bone; 2000 May; 26(5):535-43. PubMed ID: 10773596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in calcium metabolism after parathyroidectomy in primary hyperparathyroidism].
    Berczi C; Balogh A; Balázs G; Lukács G
    Orv Hetil; 2002 Mar; 143(12):597-600. PubMed ID: 11963396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimodeling reduces the rate of cortical bone loss in patients with secondary hyperparathyroidism.
    Yajima A; Inaba M; Tominaga Y; Ito A
    Am J Kidney Dis; 2007 Mar; 49(3):440-51. PubMed ID: 17336706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of parathyroidectomy on lead mobilization from bone in patients with primary hyperparathyroidism.
    Osterode W; Winker R; Bieglmayer C; Vierhapper H
    Bone; 2004 Oct; 35(4):942-7. PubMed ID: 15454101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of bone remodeling immediately after parathyroidectomy for secondary hyperparathyroidism.
    Yajima A; Ogawa Y; Takahashi HE; Tominaga Y; Inou T; Otsubo O
    Am J Kidney Dis; 2003 Oct; 42(4):729-38. PubMed ID: 14520623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased osteocyte death and mineralization inside bone after parathyroidectomy in patients with secondary hyperparathyroidism.
    Yajima A; Inaba M; Tominaga Y; Nishizawa Y; Ikeda K; Ito A
    J Bone Miner Res; 2010 Nov; 25(11):2374-81. PubMed ID: 20499355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trabecular and cortical bone in the radii of women with parathyroid adenomata: a greater trabecular deficit, with a preliminary assessment of recovery after parathyroidectomy.
    Hesp R; Tellez M; Davidson L; Elton A; Reeve J
    Bone Miner; 1987 Jul; 2(4):301-10. PubMed ID: 3505765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive changes after parathyroidectomy in patients with secondary hyperparathyroidism.
    Chou FF; Chen JB; Hsieh KC; Liou CW
    Surgery; 2008 Apr; 143(4):526-32. PubMed ID: 18374050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroidectomy followed by kidney transplantation can improve bone mineral density in patients with secondary hyperparathyroidism.
    Chou FF; Hsieh KC; Chen YT; Lee CT
    Transplantation; 2008 Aug; 86(4):554-7. PubMed ID: 18724225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone histomorphometry in 22 male patients with normocalciuric idiopathic osteoporosis.
    Ciria-Recasens M; Pérez-Edo L; Blanch-Rubió J; Mariñoso ML; Benito-Ruiz P; Serrano S; Carbonell-Abelló J
    Bone; 2005 May; 36(5):926-30. PubMed ID: 15794926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers.
    Hauge EM; Qvesel D; Eriksen EF; Mosekilde L; Melsen F
    J Bone Miner Res; 2001 Sep; 16(9):1575-82. PubMed ID: 11547826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone status after parathyroidectomy for primary hyperparathyroidism].
    Yamauchi M; Sugimoto T
    Clin Calcium; 2005 Dec; 15(12):11-16. PubMed ID: 16322668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
    Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
    Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
    Recker RR; Bare SP; Smith SY; Varela A; Miller MA; Morris SA; Fox J
    Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cortical and cancellous bone formation in glucocorticoid-treated OVX sheep.
    Schorlemmer S; Ignatius A; Claes L; Augat P
    Bone; 2005 Oct; 37(4):491-6. PubMed ID: 16046208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid improvements in cortical bone dynamics and structure after lactation in established breeder rats.
    Miller SC; Bowman BM
    Anat Rec A Discov Mol Cell Evol Biol; 2004 Feb; 276(2):143-9. PubMed ID: 14752853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does homocysteine contribute to bone disease in hyperparathyroidism?
    Alley RA; Chen EL; Beyer TD; Prinz RA
    Am J Surg; 2008 Mar; 195(3):374-7; discussion 377-8. PubMed ID: 18222411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaemia and marrow fibrosis in patients with primary hyperparathyroidism before and after curative parathyroidectomy.
    Bhadada SK; Bhansali A; Ahluwalia J; Chanukya GV; Behera A; Dutta P
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):527-32. PubMed ID: 18727711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.